SymBiosis Claims Biotech Firm's Fraud Led To Its Investment
An interest of venture capital fund SymBiosis Capital Management LLC has sued in Delaware Chancery Court to reclaim its multimillion-dollar share of a $75.5 million investment round conducted by Platelet Biogenesis...To view the full article, register now.
Already a subscriber? Click here to view full article